Whitener Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,710
Closed -$243K 139
2022
Q4
$243K Buy
+8,710
New +$223K 0.11% 119
2022
Q3
Sell
-7,740
Closed -$261K 138
2022
Q2
$261K Buy
7,740
+42
+0.5% +$1.47K 0.12% 116
2022
Q1
$268K Buy
7,698
+137
+2% +$4.68K 0.1% 121
2021
Q4
$230K Buy
+7,561
New +$246K 0.08% 132

Other funds holding OGN

Whitener Capital Management's OGN Position: Q1 2023 in Review

Whitener Capital Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 8,710 shares — an estimated $243K sold.

Whitener Capital Management first reported a position in OGN in Q4 2021 and held it in 4 quarters. The position peaked at $268K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Whitener Capital Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Whitener Capital Management sold 8,710 Organon & Co shares in Q1 2023, an estimated $243K.
  • Whitener Capital Management first reported a position in Organon & Co in Q4 2021 and held it in 4 quarters.
  • Whitener Capital Management's Organon & Co position peaked at $268K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Whitener Capital Management's 13F filing for Q1 2023, filed 12 Apr 2023.